Dr Tomasz Adam Murawski, MD | |
1055 N Curtis Rd, Boise, ID 83706-1309 | |
(208) 367-5170 | |
(208) 367-5180 |
Full Name | Dr Tomasz Adam Murawski |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 18 Years |
Location | 1055 N Curtis Rd, Boise, Idaho |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063690568 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | A101819 (California) | Secondary |
207L00000X | Anesthesiology | M-15501 (Idaho) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Saint Alphonsus Regional Medical Center | Boise, ID | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Boise Anesthesia, P A | 8426960642 | 52 |
St Alphonsus Professional Medical Services Llc | 7214849751 | 58 |
News Archive
Amid the latest surge in covid-19 cases and hospitalizations, the United States on Tuesday hit a milestone that some thought was unattainable: 90% of people 65 and older are at least partly vaccinated against the disease.
Fero Industries, Inc. is pleased to provide these comments regarding the recent Food and Drug Administration advisory panel recommendation concerning the GlaxoSmithKline PLC diabetes drug Avandia. The FDA advisory panel has recommended that the agency keep diabetes drug Avandia on the U.S. market despite data clearly showing an increased risk of a heart attack and that GSK covered up their own research that first identified the problem.
University of Cincinnati pharmaceutical sciences researcher Bingfang Yan, DVM, has received a $443,000 grant from the National Institutes of Health to study how common medicines against viral infections are genetically impacted for therapeutic effectiveness and safety through metabolic conversions in the body.
The University of York's Department of Health Sciences and NHS Leeds Community Healthcare have been awarded a £1.75m grant from the National Institute for Health Research to carry out a study into complex wounds.
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year contract with renowned eye health company Bausch & Lomb. The agreement calls for Bausch & Lomb to implement Phase Forward's InForm™ Global Trial Management (GTM) electronic data capture (EDC) solution, including the Central Coding™ module, in all of its trials, including Surgical, Vision Care and Pharmaceuticals products.
› Verified 4 days ago
Entity Name | St Alphonsus Professional Medical Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386677524 PECOS PAC ID: 7214849751 Enrollment ID: O20040205001184 |
News Archive
Amid the latest surge in covid-19 cases and hospitalizations, the United States on Tuesday hit a milestone that some thought was unattainable: 90% of people 65 and older are at least partly vaccinated against the disease.
Fero Industries, Inc. is pleased to provide these comments regarding the recent Food and Drug Administration advisory panel recommendation concerning the GlaxoSmithKline PLC diabetes drug Avandia. The FDA advisory panel has recommended that the agency keep diabetes drug Avandia on the U.S. market despite data clearly showing an increased risk of a heart attack and that GSK covered up their own research that first identified the problem.
University of Cincinnati pharmaceutical sciences researcher Bingfang Yan, DVM, has received a $443,000 grant from the National Institutes of Health to study how common medicines against viral infections are genetically impacted for therapeutic effectiveness and safety through metabolic conversions in the body.
The University of York's Department of Health Sciences and NHS Leeds Community Healthcare have been awarded a £1.75m grant from the National Institute for Health Research to carry out a study into complex wounds.
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year contract with renowned eye health company Bausch & Lomb. The agreement calls for Bausch & Lomb to implement Phase Forward's InForm™ Global Trial Management (GTM) electronic data capture (EDC) solution, including the Central Coding™ module, in all of its trials, including Surgical, Vision Care and Pharmaceuticals products.
› Verified 4 days ago
Entity Name | Boise Anesthesia, P A |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740239599 PECOS PAC ID: 8426960642 Enrollment ID: O20041022000230 |
News Archive
Amid the latest surge in covid-19 cases and hospitalizations, the United States on Tuesday hit a milestone that some thought was unattainable: 90% of people 65 and older are at least partly vaccinated against the disease.
Fero Industries, Inc. is pleased to provide these comments regarding the recent Food and Drug Administration advisory panel recommendation concerning the GlaxoSmithKline PLC diabetes drug Avandia. The FDA advisory panel has recommended that the agency keep diabetes drug Avandia on the U.S. market despite data clearly showing an increased risk of a heart attack and that GSK covered up their own research that first identified the problem.
University of Cincinnati pharmaceutical sciences researcher Bingfang Yan, DVM, has received a $443,000 grant from the National Institutes of Health to study how common medicines against viral infections are genetically impacted for therapeutic effectiveness and safety through metabolic conversions in the body.
The University of York's Department of Health Sciences and NHS Leeds Community Healthcare have been awarded a £1.75m grant from the National Institute for Health Research to carry out a study into complex wounds.
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year contract with renowned eye health company Bausch & Lomb. The agreement calls for Bausch & Lomb to implement Phase Forward's InForm™ Global Trial Management (GTM) electronic data capture (EDC) solution, including the Central Coding™ module, in all of its trials, including Surgical, Vision Care and Pharmaceuticals products.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Tomasz Adam Murawski, MD Po Box 7411114, Chicago, IL 60674-1114 Ph: (208) 367-5170 | Dr Tomasz Adam Murawski, MD 1055 N Curtis Rd, Boise, ID 83706-1309 Ph: (208) 367-5170 |
News Archive
Amid the latest surge in covid-19 cases and hospitalizations, the United States on Tuesday hit a milestone that some thought was unattainable: 90% of people 65 and older are at least partly vaccinated against the disease.
Fero Industries, Inc. is pleased to provide these comments regarding the recent Food and Drug Administration advisory panel recommendation concerning the GlaxoSmithKline PLC diabetes drug Avandia. The FDA advisory panel has recommended that the agency keep diabetes drug Avandia on the U.S. market despite data clearly showing an increased risk of a heart attack and that GSK covered up their own research that first identified the problem.
University of Cincinnati pharmaceutical sciences researcher Bingfang Yan, DVM, has received a $443,000 grant from the National Institutes of Health to study how common medicines against viral infections are genetically impacted for therapeutic effectiveness and safety through metabolic conversions in the body.
The University of York's Department of Health Sciences and NHS Leeds Community Healthcare have been awarded a £1.75m grant from the National Institute for Health Research to carry out a study into complex wounds.
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year contract with renowned eye health company Bausch & Lomb. The agreement calls for Bausch & Lomb to implement Phase Forward's InForm™ Global Trial Management (GTM) electronic data capture (EDC) solution, including the Central Coding™ module, in all of its trials, including Surgical, Vision Care and Pharmaceuticals products.
› Verified 4 days ago
Allison Elisabeth May, Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-2222 | |
John Mather Hine, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 8800 W Emerald St, Boise, ID 83704 Phone: 208-373-5000 | |
Steven J Love, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 111 W State St, Boise, ID 83702 Phone: 208-336-0895 | |
Dr. Timothy A Bialobrzeski, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 338 E Bannock St, Boise, ID 83712 Phone: 208-336-0895 | |
Brent Kenner Childers, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 8800 W Emerald St, Boise, ID 83704 Phone: 208-373-5000 | |
Kirk A. Miller, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 600 Robbins Rd, Suite 401, Boise, ID 83702 Phone: 208-489-4279 Fax: 208-424-8555 |